124 related articles for article (PubMed ID: 37230023)
21. GATA3 Exerts Distinct Transcriptional Functions to Regulate Radiation Resistance in A549 and H1299 Cells.
Wang R; Yi J; Gao H; Wei X; Shao L; Wang M; Xu W; Yin X; Shen Y; Wang Z; Wei W; Jin S
Oxid Med Cell Longev; 2022; 2022():9174111. PubMed ID: 35993027
[TBL] [Abstract][Full Text] [Related]
22. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Jacquemier J; Charafe-Jauffret E; Monville F; Esterni B; Extra JM; Houvenaeghel G; Xerri L; Bertucci F; Birnbaum D
Breast Cancer Res; 2009; 11(2):R23. PubMed ID: 19405945
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
24. The Synergistic Effect of Ruthenium Complex Δ-Ru1 and Doxorubicin in a Mouse Breast Cancer Model.
Tang XG; Lin K; Guo SW; Rong Y; Chen D; Chen ZS; Ping FF; Wang JQ
Recent Pat Anticancer Drug Discov; 2022; 18(2):174-186. PubMed ID: 35770412
[TBL] [Abstract][Full Text] [Related]
25. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
[TBL] [Abstract][Full Text] [Related]
26. Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.
Bi M; Zhang Z; Jiang YZ; Xue P; Wang H; Lai Z; Fu X; De Angelis C; Gong Y; Gao Z; Ruan J; Jin VX; Marangoni E; Montaudon E; Glass CK; Li W; Huang TH; Shao ZM; Schiff R; Chen L; Liu Z
Nat Cell Biol; 2020 Jun; 22(6):701-715. PubMed ID: 32424275
[TBL] [Abstract][Full Text] [Related]
27. USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin.
Qin T; Cui XY; Xiu H; Huang C; Sun ZN; Xu XM; Li LH; Yue L
Int J Med Sci; 2021; 18(2):325-334. PubMed ID: 33390801
[No Abstract] [Full Text] [Related]
28. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.
Bockhorn J; Dalton R; Nwachukwu C; Huang S; Prat A; Yee K; Chang YF; Huo D; Wen Y; Swanson KE; Qiu T; Lu J; Park SY; Dolan ME; Perou CM; Olopade OI; Clarke MF; Greene GL; Liu H
Nat Commun; 2013; 4():1393. PubMed ID: 23340433
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
[TBL] [Abstract][Full Text] [Related]
30. GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice.
Cornelissen LM; de Bruijn R; Henneman L; Kim Y; Zwart W; Jonkers J
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):271-284. PubMed ID: 31218575
[TBL] [Abstract][Full Text] [Related]
31.
Shahi P; Wang CY; Lawson DA; Slorach EM; Lu A; Yu Y; Lai MD; Gonzalez Velozo H; Werb Z
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3169-3174. PubMed ID: 28258171
[TBL] [Abstract][Full Text] [Related]
32. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
33. The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy.
Tanaka K; Tokunaga E; Yamashita N; Sagara Y; Ohi Y; Taguchi K; Ohno S; Okano S; Oda Y; Maehara Y
Breast Cancer; 2017 May; 24(3):384-392. PubMed ID: 27473079
[TBL] [Abstract][Full Text] [Related]
34. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
35. Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death.
Buranrat B; Connor JR
Oncol Rep; 2015 Nov; 34(5):2790-6. PubMed ID: 26352101
[TBL] [Abstract][Full Text] [Related]
36. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.
Liu J; Prager-van der Smissen WJ; Look MP; Sieuwerts AM; Smid M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
Cancer Lett; 2016 Jun; 376(1):104-9. PubMed ID: 27018307
[TBL] [Abstract][Full Text] [Related]
37. Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance.
Lu S; Yakirevich E; Wang LJ; Resnick MB; Wang Y
BMC Cancer; 2019 Nov; 19(1):1085. PubMed ID: 31718619
[TBL] [Abstract][Full Text] [Related]
38. Anticancer effects of asiatic acid against doxorubicin-resistant breast cancer cells via an AMPK-dependent pathway in vitro.
Zhu Z; Cui L; Yang J; Vong CT; Hu Y; Xiao J; Chan G; He Z; Zhong Z
Phytomedicine; 2021 Nov; 92():153737. PubMed ID: 34560519
[TBL] [Abstract][Full Text] [Related]
39. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
40. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
Kim KS; Kim J; Oh N; Kim MY; Park KS
Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
